Universidad Peruana Cayetano Heredia
Higher prevalence of extended-spectrum cephalosporin-resistant enterobacterales in dogs attended for enteric viruses in brazil before and after treatment with cephalosporins
JavaScript is disabled for your browser. Some features of this site may not work without it.
Mostrar el registro sencillo del ítem
| dc.contributor.author | Salgado-Caxito, M. | |
| dc.contributor.author | Moreno-Switt, A.I. | |
| dc.contributor.author | Paes, A.C. | |
| dc.contributor.author | Shiva Ramayoni, Carlos Martin | |
| dc.contributor.author | Munita, J.M. | |
| dc.contributor.author | Rivas, L. | |
| dc.contributor.author | Benavides, J.A. | |
| dc.date.accessioned | 2021-04-13T20:50:59Z | |
| dc.date.available | 2021-04-13T20:50:59Z | |
| dc.date.issued | 2021 | |
| dc.identifier.uri | https://hdl.handle.net/20.500.12866/9129 | |
| dc.description.abstract | The extensive use of antibiotics is a leading cause for the emergence and spread of antimicrobial resistance (AMR) among dogs. However, the impact of using antibiotics to treat viral infections on AMR remains unknown. In this study, we compared the prevalence of extended-spectrum cephalosporin-resistant Enterobacterales (ESCR-E) between dogs with a suspected infection of canine parvovirus (CPV) and canine distemper (CDV) before and after treatment with third-generation cephalosporins. We found a higher prevalence of ESCR-E faecal carriage in dogs suspected of CPV (37%) and CDV (15%) compared to dogs with noninfectious pathologies (9%) even prior to the start of their treatment. A 7-day course of ceftriaxone or ceftiofur administrated to CPV and CDV-suspected dogs substantially increased their ESCR-E faecal carriage during treatment (85% for CPV and 57% for CDV), and 4 weeks after the treatment ended (89% for CPV and 60% for CDV) when dogs were back in their households. Most of the observed resistance was carried by ESCR-E. coli carrying blaCTX-M genes. Our results suggest the need to optimize prophylactic antibiotic therapy in dogs treated for a suspected viral infection to prevent ESCR-E emergence and spread in the community. | en_US |
| dc.description.sponsorship | Este trabajo fue financiado por el International Development Research Centre of Canada bajo la dirección del Instituto Geofísico del Perú (IGP) en el marco del proyecto "Impacto de la Variabilidad y Cambio Climático en el Ecosistema de Manglares de Tumbes". | es_PE |
| dc.language.iso | eng | |
| dc.publisher | MDPI | |
| dc.relation.ispartofseries | Antibiotics | |
| dc.rights | info:eu-repo/semantics/restrictedAccess | |
| dc.rights.uri | https://creativecommons.org/licenses/by-nc-nd/4.0/deed.es | |
| dc.subject | Article | en_US |
| dc.subject | controlled study | en_US |
| dc.subject | female | en_US |
| dc.subject | male | en_US |
| dc.subject | prevalence | en_US |
| dc.subject | nonhuman | en_US |
| dc.subject | animal experiment | en_US |
| dc.subject | animal model | en_US |
| dc.subject | antibiotic resistance | en_US |
| dc.subject | antibiotic sensitivity | en_US |
| dc.subject | Antimicrobial prophylaxis | en_US |
| dc.subject | Antimicrobial resistance | en_US |
| dc.subject | aztreonam | en_US |
| dc.subject | Brazil | en_US |
| dc.subject | canine distemper | en_US |
| dc.subject | Canine distemper | en_US |
| dc.subject | Canine parvovirus | en_US |
| dc.subject | cefotaxime | en_US |
| dc.subject | cefoxitin | en_US |
| dc.subject | cefpodoxime | en_US |
| dc.subject | ceftazidime | en_US |
| dc.subject | ceftiofur | en_US |
| dc.subject | ceftriaxone | en_US |
| dc.subject | cephalosporin | en_US |
| dc.subject | Citrobacter freundii | en_US |
| dc.subject | Companion animals | en_US |
| dc.subject | dehydration | en_US |
| dc.subject | diarrhea | en_US |
| dc.subject | disk diffusion | en_US |
| dc.subject | enteric virus | en_US |
| dc.subject | Enterobacterales | en_US |
| dc.subject | ertapenem | en_US |
| dc.subject | Escherichia coli | en_US |
| dc.subject | extended spectrum beta lactamase | en_US |
| dc.subject | feces analysis | en_US |
| dc.subject | gastrointestinal disease | en_US |
| dc.subject | hyperkeratosis | en_US |
| dc.subject | imipenem | en_US |
| dc.subject | Klebsiella pneumoniae | en_US |
| dc.subject | leukopenia | en_US |
| dc.subject | mass spectrometry | en_US |
| dc.subject | matrix-assisted laser desorption-ionization mass spectrometry | en_US |
| dc.subject | meropenem | en_US |
| dc.subject | multidrug resistance | en_US |
| dc.subject | multiplex polymerase chain reaction | en_US |
| dc.subject | myoclonus | en_US |
| dc.subject | phenotype | en_US |
| dc.subject | respiratory tract disease | en_US |
| dc.subject | teaching hospital | en_US |
| dc.subject | virus infection | en_US |
| dc.subject | vomiting | en_US |
| dc.subject | zone of inhibition | en_US |
| dc.title | Higher prevalence of extended-spectrum cephalosporin-resistant enterobacterales in dogs attended for enteric viruses in brazil before and after treatment with cephalosporins | en_US |
| dc.type | info:eu-repo/semantics/article | |
| dc.identifier.doi | https://doi.org/10.3390/antibiotics10020122 | |
| dc.subject.ocde | https://purl.org/pe-repo/ocde/ford#1.06.03 | |
| dc.subject.ocde | https://purl.org/pe-repo/ocde/ford#1.06.01 | |
| dc.subject.ocde | https://purl.org/pe-repo/ocde/ford#3.01.05 | |
| dc.relation.issn | 2079-6382 |
Ficheros en el ítem
| Ficheros | Tamaño | Formato | Ver |
|---|---|---|---|
|
No hay ficheros asociados a este ítem. |
|||
Este ítem aparece en la(s) siguiente(s) colección(ones)
-
Artículos en revistas indizadas [4988]
Recuperados de bases de datos bibliográficas
Excepto si se señala otra cosa, la licencia del ítem se describe como info:eu-repo/semantics/restrictedAccess
